Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

5-Amino-1MQ Dosage Protocol | PeptideDosages.com

5-Amino-1MQ (50 mg Vial) Dosage Protocol 5-Amino-1MQ Dosage Chart 5-Amino-1MQ is dosed at 2.5 mg–5 mg daily via subcutaneous injection in educational protocols. A 50 mg vial reconstituted with bacteriostatic water yields about 12.5 mg/mL. This information is f

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

5-Amino-1MQ (50 mg Vial) Dosage Protocol

5-Amino-1MQ Dosage Chart

5-Amino-1MQ is dosed at 2.5 mg–5 mg daily via subcutaneous injection in educational protocols. A 50 mg vial reconstituted with bacteriostatic water yields about 12.5 mg/mL. This information is for research and educational use only.

Reconstitute: Add 4.0 mL bacteriostatic water → 12.5 mg/mL concentration.

Typical daily range: 2.5–5 mg once or twice daily (subcutaneous).

Easy measuring: At 12.5 mg/mL, 1 unit = 0.01 mL = 0.125 mg (125 mcg) on a U-100 insulin syringe.

Storage: Lyophilized: freeze at −20 °C (−4 °F); after reconstitution, refrigerate at 2–8 °C (35.6–46.4 °F) and use within 2–4 weeks.

5-Amino-1MQ dosage protocols center on this selective, cell-permeable NNMT (Nicotinamide N-methyltransferase) inhibitor studied for its potential to support fat metabolism, preserve lean muscle mass, and elevate intracellular NAD+ levels[1][2]. By blocking NNMT, 5-Amino-1MQ may help restore cellular energy balance and activate SIRT1 pathways associated with metabolic efficiency[3]. This educational protocol presents a subcutaneous injection approach to maximize bioavailability from the 50 mg vial format.

Research context: For evidence on mechanisms, human and preclinical research, limitations, and safety, read 5-Amino-1MQ Peptide: Benefits, Uses, Side Effects, Dosage, and Research.

Subcutaneous Protocol (4 mL = 12.5 mg/mL)

Days 1–2 (Tolerance)

2.5 mg once daily

20 units (0.20 mL)

Days 3+ (Standard)

5 mg once daily

40 units (0.40 mL)

Alternative BID

2.5 mg twice daily

20 units (0.20 mL) × 2

Frequency: Inject once or twice daily subcutaneously. Due to the compound’s plasma half-life of approximately 3.8–6.9 hours[4], twice-daily (BID) dosing may provide more sustained NNMT inhibition. A single 50 mg vial provides 10–20 days of research material at these doses.

Reconstitution Steps

Remove the vial from freezer storage (−20 °C / −4 °F) and allow to equilibrate at room temperature for 15–20 minutes.

Draw 4.0 mL bacteriostatic water with a sterile syringe.

Inject slowly down the vial wall; avoid foaming.

Gently swirl/roll until dissolved—solution should be clear (do not shake).

Label and refrigerate at 2–8 °C (35.6–46.4 °F), protected from light; use within 2–4 weeks.

Supplies Needed

Plan based on research duration using the 50 mg vial format at 5 mg/day.

1 week (5 mg/day) ≈ 1 vial

2 weeks (5 mg/day) ≈ 1 vial

4 weeks (5 mg/day) ≈ 2 vials

Per week (once daily): 7 syringes

Per week (BID): 14 syringes

4 weeks (once daily): 28 syringes

1 week (1 vial): 4 mL → 1 × 10 mL bottle

2 weeks (1 vial): 4 mL → 1 × 10 mL bottle

4 weeks (2 vials): 8 mL → 1 × 10 mL bottle

Per week (once daily): 14 swabs

4 weeks (once daily): 56 swabs → recommend 1 × 100-count box

Protocol Overview

Concise summary of the subcutaneous regimen.

Goal: Support metabolic efficiency through NNMT inhibition, potentially enhancing fat oxidation and NAD+ levels[1][2].

Schedule: Daily subcutaneous injections; each 50 mg vial provides 10–20 days of research material.

Dose Range: 2.5–5 mg once or twice daily.

Reconstitution: 4.0 mL per 50 mg vial (12.5 mg/mL) for accurate measurements.

Storage: Lyophilized frozen at −20 °C (−4 °F); reconstituted refrigerated at 2–8 °C (35.6–46.4 °F).

Dosing Protocol

Suggested approach for the 50 mg vial format.

Start: 2.5 mg once daily to assess tolerance.

Target: 5 mg once daily or 2.5 mg twice daily (BID).

Frequency: Once or twice per day (subcutaneous).

Vial Duration: Single 50 mg vial lasts 10–20 days at research doses.

Timing: Morning administration preferred; BID dosing may be split AM/PM.

Storage Instructions

Proper storage preserves compound stability.

Lyophilized: Store at −20 °C (−4 °F) in dry, dark conditions; stable up to 24 months.

Reconstituted: Refrigerate at 2–8 °C (35.6–46.4 °F); use within 2–4 weeks.

Allow vials to reach room temperature before reconstitution to prevent condensation and pressure issues.

Do not refreeze reconstituted solution.

Important Notes

Practical considerations for consistency and safety.

Use new sterile insulin syringes for each administration; dispose in a sharps container.

Rotate injection sites (abdomen, thighs, upper arms) to reduce local irritation.

Inject slowly; a mild stinging sensation may occur due to the quinolinium structure.

Document daily dose and site rotation to maintain consistency.

The 50 mg vial format is ideal for extended research cycles; a single vial can last 10–20 days.

How This Works

5-Amino-1MQ (5-amino-1-methylquinolinium) is a synthetic small molecule that selectively inhibits Nicotinamide N-methyltransferase (NNMT)[1]. NNMT is an enzyme that methylates nicotinamide (vitamin B3) using S-adenosylmethionine (SAM) as a methyl donor. In states of obesity and metabolic dysfunction, NNMT is often overexpressed in adipose tissue, depleting nicotinamide and reducing NAD+ availability[2].

By inhibiting NNMT, 5-Amino-1MQ may spare nicotinamide for NAD+ synthesis, thereby activating SIRT1 (Sirtuin 1) pathways associated with mitochondrial biogenesis and fat oxidation[3]. Preclinical studies indicate that NNMT knockdown or inhibition can protect against diet-induced weight gain and improve metabolic parameters without reducing food intake[5][6].

Potential Benefits & Side Effects

Observations from preclinical and early research literature.

May support reductions in fat mass while preserving lean muscle in animal models[5][6].

Associated with elevated NAD+ levels and SIRT1 activation in preclinical studies[2][3].

Enhanced grip strength observed in aged mice when combined with exercise[7].

Generally well tolerated; occasional reports of mild headache, transient jitteriness, or injection-site reactions.

Long-term human safety data not established; this compound remains investigational.

Lifestyle Factors

Complementary strategies for best outcomes.

Pair with a balanced, protein-forward diet tailored to energy needs.

Combine resistance training and aerobic activity—preclinical data suggest synergy with exercise[7].

Prioritize sleep and stress management to support metabolic adaptation.

Consider complementary NAD+ precursors (NMN/NR) per emerging stack protocols[8].

Injection Technique

General subcutaneous guidance from clinical best-practice resources[9].

Clean the vial stopper and skin with alcohol; allow to dry.

Pinch a skinfold; insert the needle at 45–90° into subcutaneous tissue[10][11].

Do not aspirate for subcutaneous injections; inject slowly and steadily[10].

Rotate sites systematically (abdomen, thighs, upper arms) to avoid lipohypertrophy[12].

Slow injection may minimize any stinging sensation associated with the compound.

Important Note

This content is intended for therapeutic educational purposes only and does not constitute medical advice, diagnosis, or treatment.

References

Nature Medicine (2014) — Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity View Source

PMC (2024) — Nicotinamide N-methyltransferase inhibition mitigates obesity-related metabolic dysfunctions View Source

Frontiers in Pharmacology (2024) — NNMT: a novel therapeutic target for metabolic syndrome View Source

PubMed (2021) — LC-MS/MS assay for 5-amino-1-methylquinolinium: pharmacokinetic and oral bioavailability study View Source

ResearchGate (2021) — Combined NNMT inhibition and reduced-calorie diet normalizes body composition in obese mice View Source

PMC (2022) — Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice View Source

NMN.com / Scientific Reports — Role of NNMT inhibition in muscle strength: enhanced grip strength with exercise View Source

Swolverine — 5-Amino-1MQ mechanism, benefits, stacking and cycling guide View Source

PMC — Subcutaneous drug injection review: pharmacologic considerations View Source

CDC — Vaccine administration: subcutaneous route (angle/site; no aspiration) View Source

CDC (Subcut Injection PDF) — Technique diagram and site guidance for subcutaneous injections View Source

NCBI Bookshelf — Best practices for injection (asepsis, preparation, and administration) View Source

Additional Research and Background

These sources provide related context and are not presented as support for a specific statement above.

Journal of Medicinal Chemistry (ACS) — Bisubstrate inhibitors of NNMT with enhanced activity View Source

PMC — NNMT: a bad actor in fat makes good in liver View Source

Related research, protocols, and guides

Explore the available research context, protocol variants or comparisons, and practical guides. When vial-size variants exist, they remain separate because vial strength, concentration, and syringe-unit calculations can differ. Related compounds and blends are comparisons only, not interchangeable.

Research overview

5-Amino-1MQ Peptide: Benefits, Uses, Side Effects, Dosage, and Research

Other vial-size protocols

5-Amino-1MQ (10 mg Vial) Dosage Protocol

Practical guides

Single Peptide Dosages

Peptide Dosage & Reconstitution Calculator

How to Reconstitute Peptides

Syringe & Measurement Guide

Peptide Storage Guide

Peptide Dosage Chart

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01IGF-1 DES — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 1 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 1 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. IGF-1 DES is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗
02VK2735 — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 10 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 10 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. VK2735 is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗
03Thymogen — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 10 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 10 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Thymogen is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗
04Humanin — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 5 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 5 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Humanin is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗
05Retinalamin — frequently asked questions

Wipe the stopper with an alcohol swab, then inject your bacteriostatic water slowly down the inside wall of the vial. Let it sit and gently swirl until dissolved — never shake. Store the mixed vial in the refrigerator and draw doses with an insulin syringe. Use the calculator above to turn any dose into syringe units. There is no single correct amount — more water simply spreads the same 5 mg of peptide across a larger volume, which makes small doses easier to measure accurately. 1 to 3 mL per vial is typical. Enter your chosen volume in the calculator above to see the resulting concentration and syringe units. On a U-100 insulin syringe, 100 units equal 1 mL, so 1 unit equals 0.01 mL. The calculator above converts your draw volume into these units automatically so you can measure without doing the math by hand. Keep the reconstituted vial refrigerated at roughly 2 to 8 degrees Celsius, away from light, and avoid freezing it. Reconstituted research peptides are generally used within a few weeks. Always follow the specific guidance supplied with your product. Divide the vial strength of 5 mg by the amount you use per injection. The calculator above reports this as "doses per vial" the moment you enter a dose. No. Retinalamin is sold strictly for laboratory and research purposes and is not approved by the FDA or other regulators for human use. Everything on this page is research information, not medical advice — consult a licensed healthcare professional before any use.

Source: dosagepeptide.com ↗
Research context

Read sources and limitations before applying a claim.

Study Design and Tracking

Define target area, measured amount, frequency, duration, and primary endpoint before the first observation. Use consistent lighting, camera position, facial expression, and time of day for images. Keep other skincare products and cosmetic procedures consistent or document each change. Record dispensing mass or volume so each application is reproducible. Track redness, itching, burning, swelling, dryness, eye exposure, pH drift, and product separation.

Source: peptidedosages.com ↗

Handling and Reconstitution in a Research Context

Because AOD-9604 is most often encountered as a lyophilized (freeze-dried) powder in a sealed vial, a brief, strictly educational note on laboratory handling is warranted — with the emphasis that this is standard research-peptide practice, not a usage recommendation, and that AOD-9604 is not an approved therapeutic for any indication. Lyophilized peptides are generally reconstituted with sterile or bacteriostatic water for laboratory purposes. The diluent is directed slowly against the inside wall of the vial rather than sprayed onto the powder, and the vial is gently swirled rather than shaken, because vigorous agitation can shear peptide bonds and denature the material. The volume of diluent chosen simply sets the concentration: a fixed mass of peptide dissolved in a larger volume yields a lower concentration per unit volume, the arithmetic underlying any reconstitution chart. Standard stability and storage considerations recur across the research-peptide literature. Lyophilized storage Cool, dark conditions; long-term stability favored by freezing After reconstitution Refrigerated; used within a limited window Light and heat Minimize exposure; both can degrade peptides Agitation Swirl gently; avoid shaking or foaming Freeze-thaw Repeated cycles degrade peptides; avoid Sterility Aseptic technique; bacteriostatic water for multi-use practice It bears repeating that meticulous handling changes nothing about the evidence question. A perfectly reconstituted, high-purity vial of AOD-9604 is still a compound whose antilipogenic action is documented only preclinically and never quantified in humans. Good technique preserves whatever biological activity the molecule has; it does not create efficacy where none has been demonstrated. Researchers surveying how these compounds are cataloged can consult the site’s central dosages index, organized for educational reference rather than as guidance for human use.

Source: dosagepeptide.com ↗
Practical and safety references

These excerpts are educational, not personalised medical instructions.

How-to reference

How to convert mcg to mg (and back)

Because the factor is exactly 1000, every conversion is a decimal-point move of three places — no calculator strictly required once you see the pattern: mcg → mg: divide by 1000, i.e. move the decimal point three places to the left. 500 mcg → 0.5 mg; 100 mcg → 0.1 mg; 1500 mcg → 1.5 mg. mg → mcg: multiply by 1000, i.e. move the decimal point three places to the right. 0.5 mg → 500 mcg; 2 mg → 2000 mcg; 1.25 mg → 1250 mcg. The tool above does the same move for you and trims trailing zeros, so you can paste in any value — whole or fractional — and read the exact counterpart.

Source: dosagepeptide.com ↗
Dosage reference

5. Requesting a Dosage Protocol

Our Website allows you to request a dosage protocol at no cost. By submitting a request, you agree to provide accurate, current, and complete information. We reserve the right to decline any request for any reason. We do not guarantee the accuracy, completeness, or suitability of the dosage protocol for your specific needs. You assume any risks associated with using the information you receive from us.

Source: dosagepeptide.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →